Latest News

Alimentary Health enters partnership with Norgine.

26th August 2011.  Alimentary Health Limited (AH), the specialty biotechnology company, today announces that it has entered into a development partnership with Norgine, a leading European specialty pharmaceutical company with a strong portfolio of internal development projects, principally in t

Xention Initiates Human Clinical Testing of New Atrial Fibrillation Drug.

27 July 2011.  XENTION LTD., the Cambridge-based biopharmaceutical company specialising in the discovery and development of ion channel-modulating drugs, announced today that it has initiated phase 1 clinical development of XEN-D0103, an innovative new drug for the treatment and prevention of a

Opsona Therapeutics announces Phase 1 clinical trial.

5 July 2011, DUBLIN, Ireland.  Opsona Therapeutics, a biotechnology company focused on novel therapeutic approaches to treat autoimmune and inflammatory diseases today announced that it has initiated a phase 1 clinical trial in healthy volunteers with its lead drug candidate OPN-305.  This